Skip to main content
NCBI home page
Plants logoLink to Plants
. 2021 Feb 24;10(3):431. doi: 10.3390/plants10030431

(-)-Leucophyllone, a Tirucallane Triterpenoid from Cornus walteri, Enhances Insulin Secretion in INS-1 Cells

Dahae Lee 1, Ki Hyun Kim 2, Taesu Jang 3,*, Ki Sung Kang 1,*
Editor: Filippo Maggi
PMCID: PMC7996230  PMID: 33668330

Abstract

Phytochemical examination of the MeOH extract from the stems and stem bark of Cornus walteri (Cornaceae) led to the isolation and verification of a tirucallane triterpenoid, (-)-leucophyllone, as a major component. Its structure was elucidated using NMR spectroscopy and liquid chromatography–mass spectrometry. The effect of (-)-leucophyllone on insulin secretion in INS-1 cells was investigated. (-)-Leucophyllone increased glucose-stimulated insulin secretion (GSIS) at concentrations showing no cytotoxic effect in rat INS-1 pancreatic β-cells. Moreover, we attempted to determine the mechanism of action of (-)-leucophyllone in the activation of insulin receptor substrate-2 (IRS-2), phosphatidylinositol 3-kinase (PI3K), Akt, and pancreatic and duodenal homeobox-1 (PDX-1). Treatment of INS-1 cells with (-)-leucophyllone markedly increased the expression of these proteins. Our findings indicate the potential of (-)-leucophyllone as an antidiabetic agent.

Keywords: Cornus walteri, cornaceae, (-)-leucophyllone, glucose-stimulated insulin secretion, PDX-1

1. Introduction

Type 2 diabetes (T2D) is a chronic metabolic disorder primarily characterized by reduced insulin secretion, and its global incidence has been on the rise [1]. Glucose-stimulated insulin secretion (GSIS) is generally accepted as the main mechanism of insulin secretion [2]. Insufficient insulin secretion is a known defect in pancreatic β-cell function [3]. Thus, maintaining or enhancing pancreatic β-cell function could be a strategic approach for the prevention and treatment of T2D.

Several natural products isolated from plants, on account of their complex chemical structures, are known for their biological potency as drugs [4]. In particular, compounds isolated from various plants have been reported to enhance insulin secretion via the regulation of pancreatic β-cell function, including cytopiloyne from Bidens pilosa [5], capsaicin from Capsicum annuum [6], berberine from Rhizoma coptidis [7], curcumin from Curcuma longa [8], epigallocatechin-3-gallate from Camellia sinensis [9], and genistein from Glycine max [10]. However, very little is known about their possible mechanisms of action.

Cornus walteri Wanger, better known as Walter’s dogwood, is a deciduous shrub belonging to the family Cornaceae. This medicinal plant has received attention for its anti-photoaging and anti-diarrheal effects [11,12]. In addition, its extracts possess anti-hyperglycemic [13], anti-inflammatory [14], anti-oxidant, and anti-obesity effects [15]. This bioactive potential of C. walteri necessitates its detailed phytochemical investigation. Our previous phytochemical analysis on C. walteri led to the isolation of triterpenoids, including betulinic acid methyl ester, lupenone, lupeol, betulinic acid, methyl 3-O-acetyl betulinate, and sterols such as 6β-hydroxysitostenone, 5α-stigmast-3,6-dione, sitostenone, 3β-sitostanol, and 6α-hydroxy-β-sitostenone [16,17]. Among them, the anticancer effect of betulinic acid on A2780 human ovarian cancer cells and the renoprotective effect of benzyl salicylate on cisplatin-induced damage in LLC-PK1 kidney proximal tubule cells have been explored and evaluated in our previous studies [16,17]. In the present study, we focused on (-)-leucophyllone, a tirucallane triterpenoid isolated from the further phytochemical investigation of the MeOH extract from C. walteri. To the best of our knowledge, the biological activity of (-)-leucophyllone has not been reported. Therefore, we explored the insulin enhancement effect of (-)-leucophyllone in rat INS-1 pancreatic β-cells. Additionally, we studied the mechanism of action of (-)-leucophyllone in the activation of insulin receptor substrate-2 (IRS-2), phosphatidylinositol 3-kinase (PI3K), Akt, and pancreatic and duodenal homeobox-1 (PDX-1).

2. Results

2.1. Isolation and Identification of (-)-Leucophyllone from C. walteri

Phytochemical analysis of the MeOH extract from the stems and stem bark of C. walteri, using successive column chromatography on silica gel and RP-C18 silica along with semi-preparative HPLC, resulted in the isolation and verification of (-)-leucophyllone from the hexane-soluble fraction. (-)-Leucophyllone was isolated as a white amorphous powder, and its molecular formula of C31H50O2 was determined based on LC/MS data at m/z 477.7 [M+ Na]+. The 1H (Figure S1) and 13C NMR (Figure S2) data of (-)-leucophyllone suggested the characteristic NMR spectroscopic values for eight methyl groups, one trans-disubstituted olefinic bond, one trisubstituted olefinic bond, one methoxy group, and one ketone group at δC 216.9, which were identical to the values of (-)-leucophyllone, an analogue of tirucallane-type triterpenoids reported from Aglaia leucophylla [18]. By comparing its negative value of optical specific data with previously reported data of (-)-leucophyllone [18], the absolute configuration of (-)-leucophyllone was determined as shown in Figure 1. Accordingly, the structural elucidation of (-)-leucophyllone isolated was unambiguously confirmed (Figure 1).

Figure 1.

Figure 1

Open in a new tab

Chemical structure of (-)-leucophyllone.

2.2. Glucose-Stimulated Insulin Secretion (GSIS) Effect

In this study, we investigated whether (-)-leucophyllone could enhance GSIS and if it was cytotoxic to INS-1 cells. (-)-Leucophyllone at 2.5 μM, 5 μM, and 10 μM was found to be nontoxic to INS-1 cells (Figure 2A). The non-toxic concentrations of (-)-leucophyllone were tested to determine if they led to an increase in GSIS. As shown in Figure 2B, (-)-leucophyllone increased GSIS (ng/mL per 400,000 cells). GSIS was expressed as the glucose-stimulated index (GSI). Fold change was set at 1 for control. The resultant GSI values were found to be 5.16 ± 0.12 and 13.11 ± 0.17 for (-)-leucophyllone at 5 μM and 10 μM, respectively (Figure 2C). The results suggested that (-)-leucophyllone enhanced insulin secretion in response to high glucose without causing exhibiting toxicity to INS-1 cells.

Figure 2.

Figure 2

Open in a new tab

Effect of (-)-leucophyllone on glucose-induced insulin secretion in INS-1 cells. (A) Effect of (-)-leucophyllone on the viability of INS-1 cells following 24 h of incubation, compared to that of the control (0 μM), as determined by cell viability assay. (B) Effect of (-)-leucophyllone on glucose-stimulated insulin secretion (glucose-stimulated insulin secretion (GSIS), ng/mL per 400,000 cells) in INS-1 cells following 1 h of treatment, compared to that of the control (0 μM), as determined using the GSIS assay. (C) Comparison of GSIS is expressed as fold-stimulation in terms of the glucose-stimulated index (GSI, 16.7 mM glucose over 2.8 mM glucose for 1h). n = 3 independent experiments, * p < 0.05, Kruskal–Wallis non-parametric test. The data are presented as the mean ± SEM.

2.3. Protein Expression of IRS-2 (Ser731), P-IRS-2, PI3K, P-PI3K, Akt, P-Akt (Ser473), and PDX-1

Treatment with (-)-leucophyllone at 5 μM and 10 μM increased the protein expression of IRS-2, PI3K, Akt, and PDX-1 compared to the untreated controls in INS-1 cells (Figure 3). These results suggested that (-)-leucophyllone upregulated PDX-1 expression via the IRS-2/PI3K/Akt signaling pathway in INS-1 cells. A schematic illustration of the proposed mechanisms of the effect of (-)-leucophyllone on pancreatic β-cell metabolism is shown in Figure 4.

Figure 3.

Figure 3

Open in a new tab

Effect of (-)-leucophyllone on the protein expression levels of insulin receptor substrate-2 (IRS-2) (Ser731), P-IRS-2, P-phosphatidylinositol 3-kinase (PI3K), PI3K, P-Akt (Ser473), Akt, and pancreatic and duodenal homeobox-1 (PDX-1) in INS-1 cells. (A) Protein expression levels of P-IRS-2 (Ser731), IRS-2, P-PI3K, PI3K, P-Akt (Ser473), Akt, PDX-1, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in INS-1 cells treated or untreated with 5 and 10 μM (-)-leucophyllone for 24 h. (B–E) Each bar graph presents the densitometric quantification of western blot bands. * p < 0.05 compared to the control (0 μM).

Figure 4.

Figure 4

Open in a new tab

Schematic illustration of the effect of (-)-leucophyllone isolated from C. walteri on the protein expression levels of insulin receptor substrate-2 (IRS-2), phosphatidylinositol 3-kinase (PI3K), Akt, and pancreatic and duodenal homeobox-1 (PDX-1) in INS-1 cells.

3. Discussion

Insulin is the only hormone responsible for lowering plasma glucose levels. Glucose homeostasis is maintained when the insulin secretion is normal [19]. Because GSIS is a vital concept in the development of T2D, it needs to be explored as a strategy to discover novel bioactive compounds to treat T2D [20]. In the present study, we investigated whether (-)-leucophyllone could enhance GSIS. Moreover, we evaluated its cytotoxicity in INS-1 cells. Based on our results, we concluded that while (-)-leucophyllone did not increase cell viability; it also did not induce cytotoxicity at any concentration that was used in our study. In addition, we found that (-)-leucophyllone enhanced insulin secretion in response to high glucose levels in INS-1 cells. Therefore, we suggest that (-)-leucophyllone may enhance GSIS by modulating cellular signals rather than increasing the viability of insulin-secreting cells.

Flavonoids are known to upregulate protein expression, including the expression of IRS-2 and PDX-1, thereby enhancing insulin secretion in pancreatic β cells [21]. Phosphorylated IRS-2 has essential roles, including the regulation of normal pancreatic β-cell function, particularly, the maintenance of pancreatic β-cell mass and activation of the PI3K/Akt pathway [22,23]. Although its role is not fully understood, the PI3K/Akt pathway is critical for the nuclear translocation of PDX-1 [24,25]. PDX-1 is a crucial transcription factor that maintains pancreatic β-cell function in normal GSIS and activates the insulin gene promoter [26,27]. Its deficiency has been shown to cause defective GSIS in mouse and human pancreatic β cells [26,28,29]. The polyphenol extract of Caesalpinia bonduc was previously shown to enhance insulin secretion and PDX-1 expression in pancreatic β cells of rats [30]. It has been demonstrated that the extract of mistletoe (Viscum album coloratum) has an insulin-secreting effect through the activation of PDX-1 in alloxan-induced diabetic mice [31]. Another study showed that the polysaccharide extracted from mulberry (Morus alba L.) leaf ameliorated insulin-secreting activity by increasing PDX-1 expression through nuclear localization in the pancreatic β cells of diabetic rats [32].

In our study, we also investigated the involvement of the pathway associated with β-cell function in INS-1 cells after treatment with (-)-leucophyllone. Our results were consistent with the theory suggested by previous studies that PDX-1 expression via the IRS-2/PI3K/Akt signaling pathway played a key role in insulin secretory capacity. In the current study, treatment with (-)-leucophyllone increased the protein expression of IRS-2, PI3K, Akt, and PDX-1 compared to untreated controls in INS-1 cells. These results established the underlying mechanism of action of (-)-leucophyllone to enhance GSIS. However, the biggest drawback of natural product research is still difficult to separate enough components for animal testing, and we need to further study the mechanism of action using other experimental models and diabetic animals in future studies.

4. Materials and Methods

4.1. Extraction, Fractionation, and Purification Methods

Cornus walteri stems and stem bark (2.5 kg) were dried, chopped, and extracted with 80% aqueous MeOH (2 × 6 h) under reflux, and the resultant extract was filtered. The filtrate was concentrated using evaporator under vacuum to afford a MeOH extract (220 g), which was applied to distilled H2O (7.2 L) and then successively solvent-partitioned with three organic solvents including hexane, CHCl3, and n-BuOH, providing 9.5, 25, and 43 g of residue, respectively. The hexane-soluble fraction (9.5 g) was chromatographed on a 300 g of silica gel column eluted with hexane-EtOAc (3:1 to 1:1, gradient solvent system) to yield fractions F1–F5. Fraction F1 (3.3 g) was chromatographed on a 100 g of RP-C18 silica gel column eluted with 100% MeOH to yield subfractions F11–F15. Fraction F14 (300 mg) was subjected to medium pressure liquid chromatography (MPLC) using a LiChroprep Lobar-A Si gel 60 column (n-hexane-EtOAc, 16:1) and then purified using semi-preparative normal-phase HPLC and a solvent system comprising n-hexane:EtOAc (12:1) to yield (-)-leucophyllone (30 mg, 0.0136%).

4.2. Cell Culture

Rat pancreatic β-cells (INS-1) were purchased from Biohermes (Shanghai, China). INS-1 cells were routinely maintained in RPMI-1640 (Cellgro, Manassas, VA, USA) containing 11 mM d-glucose, 10% fetal bovine serum, 1% penicillin/streptomycin (Invitrogen Co., Grand Island, NY, USA), 0.05 mM 2-mercaptoethanol, 2 mM l-glutamine, 10 mM HEPES, and 1 mM sodium pyruvate under 5% CO2 and 95% humidity at 37 °C.

4.3. Measurement of Cell Viability

To assess the non-toxic dose range of (-)-leucophyllone, INS-1 cells (1 × 104 cells/well) were seeded in 96-well plates for 24 h. Cells were then treated with 2.5, 5, or 10 μM (-)-leucophyllone for 24 h. EZ-Cytox cell viability assay solution (100 μL; Daeil Lab Service Co., Seoul, Korea) was added to the plates and incubated for 40 min. Next, the absorbance of the samples in the wells was measured using a PowerWave XS microplate reader (Bio-Tek Instruments, Winooski, VT, USA) at a wavelength of 450 nm as previously described [33,34].

4.4. GSIS Assay

INS-1 cells (4 × 105 cells/well) were seeded in 12-well plates for 24 h. Cells were then carefully washed twice with warm Krebs–Ringer bicarbonate buffer (KRBB, 4.8 mM KCl, 129 mM NaCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 2.5 mM CaCl2, 10 mM HEPES, 5 mM NaHCO3, and 0.1% bovine serum albumin (pH 7.4). Then, INS-1 cells were starved with fresh KRBB for 2 h and treated with 2.5, 5, and 10 μM (-)-leucophyllone for 1 h. Thereafter, INS-1 cells were stimulated with fresh KRBB containing 2.8 mM or 16.7 mM glucose for 1 h. The culture supernatant was immediately collected and used to measure the GSIS according to the manufacturer’s instructions for the rat insulin ELISA kit (Gentaur, Shibayagi Co. Ltd., Gunma, Shibukaw, Japan). GSIS is expressed as fold-stimulation in terms of the glucose-stimulated index (16.7 mM glucose over 2.8 mM glucose for 1 h).

4.5. Western Blotting

INS-1 cells (8 × 105 cells/well) were seeded in six-well plates for 24 h. Cells were then treated with 5 or 10 μM (-)-leucophyllone for 24 h. To extract the whole protein lysate, INS-1 cells were lysed for 20 min on ice in RIPA buffer (Cell Signaling, Danvers, MA, USA) containing a protease inhibitor. Protein samples (20 μg) were separated and detected as previously described [35,36].

4.6. Statistical Analysis

Statistical significance was assessed using one-way analysis of variance (ANOVA) and multiple comparisons with a Bonferroni correction. p values less than 0.05 indicated statistical significance. All analyses were performed using SPSS Statistics ver. 19.0 (SPSS Inc., Chicago, IL, USA).

5. Conclusions

Based on the results from our study, we conclude that (-)-leucophyllone identified from C. walteri was capable of GSIS. These effects were supported by the increased expression of IRS-2, PI3K, Akt, and PDX-1. Further studies are necessary to investigate the impact of (-)-leucophyllone on insulin secretion in animal models of T2D and to evaluate whether (-)-leucophyllone might be of therapeutic interest for the treatment of T2D in humans.

Supplementary Materials

The following are available online at https://www.mdpi.com/2223-7747/10/3/431/s1, general experimental procedures, plant material, Figure S1: The 1H NMR spectrum of (-)-leucophyllone (CDCl3, 500 MHz); Figure S2: The 13C NMR spectrum of (-)-leucophyllone (CDCl3, 125 MHz).

Click here for additional data file. (409.6KB, pdf)

Author Contributions

Conceptualization, K.S.K. and T.J.; methodology, D.L.; validation, D.L. and K.H.K.; formal analysis, D.L.; investigation, K.H.K.; writing—original draft preparation, D.L.; writing—review and editing, K.S.K. and T.J. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Ministry of Trade, Industry, and Energy (MOTIE) and Korea Institute for Advancement of Technology (KIAT), through the program for smart specialization infrastructure construction.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Hameed I., Masoodi S.R., Mir S.A., Nabi M., Ghazanfar K., Ganai B.A. Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition. World J. Diabetes. 2015;6:598. doi: 10.4239/wjd.v6.i4.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Seino S., Shibasaki T., Minami K. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J. Clin. Investig. 2011;121:2118–2125. doi: 10.1172/JCI45680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Clark A., Jones L.C., de Koning E., Hansen B.C., Matthews D.R. Decreased insulin secretion in type 2 diabetes: A problem of cellular mass or function? Diabetes. 2001;50:S169. doi: 10.2337/diabetes.50.2007.S169. [DOI] [PubMed] [Google Scholar]
  • 4.Katiyar C., Gupta A., Kanjilal S., Katiyar S. Drug discovery from plant sources: An integrated approach. Ayu. 2012;33:10. doi: 10.4103/0974-8520.100295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Chang C.L.-T., Liu H.-Y., Kuo T.-F., Hsu Y.-J., Shen M.-Y., Pan C.-Y., Yang W.-C. Antidiabetic effect and mode of action of cytopiloyne. Evid. Based Complement. Altern. Med. 2013;2013:685642. doi: 10.1155/2013/685642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Akiba Y., Kato S., Katsube K.-I., Nakamura M., Takeuchi K., Ishii H., Hibi T. Transient receptor potential vanilloid subfamily 1 expressed in pancreatic islet β cells modulates insulin secretion in rats. Biochem. Biophys. Res. Commun. 2004;321:219–225. doi: 10.1016/j.bbrc.2004.06.149. [DOI] [PubMed] [Google Scholar]
  • 7.Leng S.-H., Lu F.-E., Xu L.-J. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol. Sin. 2004;25:496–502. [PubMed] [Google Scholar]
  • 8.Best L., Elliott A.C., Brown P.D. Curcumin induces electrical activity in rat pancreatic β-cells by activating the volume-regulated anion channel. Biochem. Pharmacol. 2007;73:1768–1775. doi: 10.1016/j.bcp.2007.02.006. [DOI] [PubMed] [Google Scholar]
  • 9.Cai E.P., Lin J.-K. Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic β cells. J. Agric. Food Chem. 2009;57:9817–9827. doi: 10.1021/jf902618v. [DOI] [PubMed] [Google Scholar]
  • 10.Ohno T., Kato N., Ishii C., Shimizu M., Ito Y., Tomono S., Kawazu S. Genistein augments cyclic adenosine 3’5’-monophosphate(cAMP) accumulation and insulin release in MIN6 cells. Endocr. Res. 1993;19:273–285. doi: 10.1080/07435809309026682. [DOI] [PubMed] [Google Scholar]
  • 11.Choi W.-H., Park W.-Y., Hwang B.-Y., Oh G.-J., Kang S.-J., Lee K.-S., Ro J.-S. Phenolic compounds from the stem bark of Cornus walteri Wanger. Korean J. Pharmacogn. 1998;29:217–224. [Google Scholar]
  • 12.Park H.-C., Jung T.K., Kim M.J., Yoon K.-S. Protective effect of Cornus walteri Wangerin leaf against UVB irradiation induced photoaging in human reconstituted skin. J. Ethnopharmacol. 2016;193:445–449. doi: 10.1016/j.jep.2016.09.006. [DOI] [PubMed] [Google Scholar]
  • 13.Lim C.-S., Li C.-Y., Kim Y.-M., Lee W.-Y., Rhee H.-I. The inhibitory effect of Cornus walteri extract against α−amylase. Appl. Biol. Chem. 2005;48:103–108. [Google Scholar]
  • 14.Lee S.-H., Yoon K.-R., Lee E., Cha Y.-Y. Anti-inflammatory effect of Cornus walteri. J. Physiol. Pathol. Korean Med. 2011;25:982–988. [Google Scholar]
  • 15.Park W.-H., Cha Y.-Y. Effects of stem bark extracts of Cornus walteri Wanger on the lipid lowering, anti-oxidative activity and concentration of proinflammatory cytokines in rat fed high fat diet. J. Korean Med. Rehabil. 2009;19:59–78. [Google Scholar]
  • 16.Lee D., Lee S.R., Kang K.S., Ko Y., Pang C., Yamabe N., Kim K.H. Betulinic acid suppresses ovarian cancer cell proliferation through induction of apoptosis. Biomolecules. 2019;9:257. doi: 10.3390/biom9070257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lee D., Lee S.R., Kang K.S., Kim K.H. Benzyl salicylate from the stems and stem barks of Cornus walteri as a nephroprotective agent against cisplatin-induced apoptotic cell death in LLC-PK1 cells. RSC Adv. 2020;10:5777–5784. doi: 10.1039/C9RA07009E. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Benosman A., Richomme P., Sevenet T., Perromat G., Hadi A.H.A., Bruneton J. Tirucallane triterpenes from the stem bark of Aglaia leucophylla. Phytochemistry. 1995;40:1485–1487. doi: 10.1016/0031-9422(95)00415-4. [DOI] [Google Scholar]
  • 19.Komatsu M., Takei M., Ishii H., Sato Y. Glucose-stimulated insulin secretion: A newer perspective. J. Diabetes Investig. 2013;4:511–516. doi: 10.1111/jdi.12094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kahn B.B. Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance. Cell. 1998;92:593–596. doi: 10.1016/S0092-8674(00)81125-3. [DOI] [PubMed] [Google Scholar]
  • 21.Soares J.M.D., Pereira Leal A.E.B., Silva J.C., Almeida J., de Oliveira H.P. Influence of flavonoids on mechanism of modulation of insulin secretion. Pharmacogn. Mag. 2017;13:639–646. doi: 10.4103/pm.pm_87_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 2002;283:E413–E422. doi: 10.1152/ajpendo.00514.2001. [DOI] [PubMed] [Google Scholar]
  • 23.Costa M.M., Violato N.M., Taboga S.R., Góes R.M., Bosqueiro J.R. Reduction of insulin signalling pathway IRS-1/IRS-2/AKT/mTOR and decrease of epithelial cell proliferation in the prostate of glucocorticoid-treated rats. Int. J. Exp. Pathol. 2012;93:188–195. doi: 10.1111/j.1365-2613.2012.00817.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Li J.-M., Wang W., Fan C.-Y., Wang M.-X., Zhang X., Hu Q.-H., Kong L.-D. Quercetin preserves β-cell mass and function in fructose-induced hyperinsulinemia through modulating pancreatic Akt/FoxO1 activation. Evid. Based Complement. Altern. Med. 2013;2013:303902. doi: 10.1155/2013/303902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Zhang B., Sun P., Liu X., Sun J., Li D., Liu Z., Zhang W., Zhang K., Niu Y. Role and mechanism of PI3K/AKT/FoxO1/PDX-1 signaling pathway in functional changes of pancreatic islets in rats after severe burns. Life Sci. 2020;258:118145. doi: 10.1016/j.lfs.2020.118145. [DOI] [PubMed] [Google Scholar]
  • 26.Gauthier B.R., Wiederkehr A., Baquié M., Dai C., Powers A.C., Kerr-Conte J., Pattou F., MacDonald R.J., Ferrer J., Wollheim C.B. PDX1 deficiency causes mitochondrial dysfunction and defective insulin secretion through TFAM suppression. Cell Metab. 2009;10:110–118. doi: 10.1016/j.cmet.2009.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhu Y., Liu Q., Zhou Z., Ikeda Y. PDX1, Neurogenin-3, and MAFA: Critical transcription regulators for beta cell development and regeneration. Stem Cell Res. Ther. 2017;8:1–7. doi: 10.1186/s13287-017-0694-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Brissova M., Shiota M., Nicholson W.E., Gannon M., Knobel S.M., Piston D.W., Wright C.V., Powers A.C. Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J. Biol. Chem. 2002;277:11225–11232. doi: 10.1074/jbc.M111272200. [DOI] [PubMed] [Google Scholar]
  • 29.Wang X., Sterr M., Burtscher I., Böttcher A., Beckenbauer J., Siehler J., Meitinger T., Häring H.-U., Staiger H., Cernilogar F.M. Point mutations in the PDX1 transactivation domain impair human β-cell development and function. Mol. Metab. 2019;24:80–97. doi: 10.1016/j.molmet.2019.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Iftikhar A., Aslam B., Iftikhar M., Majeed W., Batool M., Zahoor B., Amna N., Gohar H., Latif I. Effect of Caesalpinia bonduc polyphenol extract on alloxan-induced diabetic rats in attenuating hyperglycemia by upregulating insulin secretion and inhibiting JNK signaling pathway. Oxid. Med. Cell. Longev. 2020;2020:9020219. doi: 10.1155/2020/9020219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kim K.-W., Yang S.-H., Kim J.-B. Protein fractions from Korean mistletoe (Viscum album coloratum) extract induce insulin secretion from pancreatic beta cells. Evid. Based Complement. Altern. Med. 2014;2014:703624. doi: 10.1155/2014/703624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zhang Y., Ren C., Lu G., Mu Z., Cui W., Gao H., Wang Y. Anti-diabetic effect of mulberry leaf polysaccharide by inhibiting pancreatic islet cell apoptosis and ameliorating insulin secretory capacity in diabetic rats. Int. Immunopharmacol. 2014;22:248–257. doi: 10.1016/j.intimp.2014.06.039. [DOI] [PubMed] [Google Scholar]
  • 33.Kim H., Choi P., Kim T., Kim Y., Song B.G., Park Y.-T., Choi S.-J., Yoon C.H., Lim W.-C., Ko H. Ginsenosides Rk1 and Rg5 inhibit transforming growth factor-β1-induced epithelial-mesenchymal transition and suppress migration, invasion, anoikis resistance, and development of stem-like features in lung cancer. J. Ginseng Res. 2021;45:134–148. doi: 10.1016/j.jgr.2020.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hong S.-H., Hwang H.-J., Kim J.W., Kim J.A., Lee Y.B., Roh E., Choi K.M., Baik S.H., Yoo H.J. Ginsenoside compound-Mc1 attenuates oxidative stress and apoptosis in cardiomyocytes through an AMP-activated protein kinase–dependent mechanism. J. Ginseng Res. 2020;44:664–671. doi: 10.1016/j.jgr.2019.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hoa H.T., Thu N.T., Dong N.T., Oanh T.T., Hien T.T., Ha D.T. Effects of compounds from Physalis angulata on fatty acid synthesis and glucose metabolism in HepG2 cells via the AMP-activated protein kinase pathway. Nat. Prod. Sci. 2020;26:200–206. [Google Scholar]
  • 36.Ryu Y.-S., Hyun J.-W., Chung H.-S. Fucoidan induces apoptosis in A2058 cells through ROS-exposed activation of MAPKs signaling pathway. Nat. Prod. Sci. 2020;26:191–199. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (409.6KB, pdf)

Data Availability Statement

Not applicable.

Articles from Plants are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES